Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Polaris begins enrollment in phase II trial of ADI-PEG 20 in malignant mesothelioma

March 21, 2011

CHMP adopts negative opinion for Vectibix in combination with chemotherapy

March 21, 2011

Nerviano enters into oncology license agreement with Novartis

March 21, 2011

New B-raf inhibitors reported by Array BioPharma and Genentech

March 21, 2011

SPINK1 identified as potential therapeutic target in prostate cancer

March 21, 2011

Phase I trial of AZD-8055 in subjects with recurrent gliomas to begin this month

March 18, 2011

Antisense Therapeutics continues seeking partner for ATL-1101 in prostate cancer

March 18, 2011

Senesco's study of SNS01-T in multiple myeloma on hold by FDA

March 18, 2011

Ariad and Merck & Co. to copromote ridaforolimus for sarcoma in U.S.

March 18, 2011

CytRx begins phase Ib INNO-206 study in advanced solid tumors

March 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...